Having trouble accessing articles? Reset your cache.

Product Development
Singapore deploys antibody testing for COVID-19

The Singapore Ministry of Health has used an antibody test developed by the Duke-NUS Medical School to determine the source of a COVID-19 cluster. The ministry

Regulatory Roundup: FDA reviewing GSK, Takeda applications for earlier lines of cancer treatment; plus Novartis, Halozyme-Genentech, MacroGenics, CSL, Lilly

FDA is reviewing four earlier or additional indications for a slate of cancer drugs, plus a first-time application for MacroGenics’ anti-HER2 mAb. The agency also approved the ...

Feb. 25 Quick Takes: Vanda’s Phase III miss; plus Iovance; 1st-twoXAR; app for AFib, stroke; ICER-Aetion; new-look Purple Book, and more

Vanda’s itch therapy misses in atopic dermatitis
Vanda Pharmaceuticals Inc. (NASDAQ:VNDA) shares tumbled after market close Tuesday after ...

Politics, Policy & Law
White House requests $2.5B for COVID-19

The Trump administration has asked Congress for $1.8 billion in additional funding to address the COVID-19 outbreak, which would bring the total U.S. government commitment to $2.5 ...

Bicycle’s bicyclic peptides attract Genentech as first corporate immuno-oncology partner

Bicycle is tapping the value of its bicyclic peptide platform through its first broad partnership in immuno-oncology. Via the early discovery deal with Genentech, Bicycle will ...

Vir, WuXi collaborating on COVID-19 mAbs

Vir and WuXi Biologics announced Tuesday a collaboration to develop and manufacture mAbs to treat COVID-19. The partnership combines Vir’s mAb discovery engine with WuXi’s ...

BioCentury ISSN 1097-7201